| Brand: | Abnova |
| Reference: | H00002066-Q01 |
| Product name: | ERBB4 (Human) Recombinant Protein (Q01) |
| Product description: | Human ERBB4 partial ORF ( NP_005226, 26 a.a. - 125 a.a.) recombinant protein with GST-tag at N-terminal. |
| Gene id: | 2066 |
| Gene name: | ERBB4 |
| Gene alias: | HER4|MGC138404|p180erbB4 |
| Gene description: | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
| Genbank accession: | NM_005235 |
| Immunogen sequence/protein sequence: | QSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSVREVTGYVLVALNQFRYLPLENLRIIRGTKLYEDRYALAIFLNYRK |
| Protein accession: | NP_005226 |
| Preparation method: | in vitro wheat germ expression system |
| Storage buffer: | 50 mM Tris-HCI, 10 mM reduced Glutathione, pH=8.0 in the elution buffer. |
| Storage instruction: | Store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | 12.5% SDS-PAGE Stained with Coomassie Blue. |
| Quality control testing picture: |  |
| Note: | Best use within three months from the date of receipt of this protein. |
| Tag: | GST |
| Product type: | Proteins |
| Host species: | Wheat Germ (in vitro) |
| Antigen species / target species: | Human |
| Applications: | AP,Array,ELISA,WB-Re |
| Shipping condition: | Dry Ice |
| Publications: | Targeting Trastuzumab-Resistant HER2+ Breast Cancer with a HER3-Targeting Nanoparticle.Medina-kauwe LK, Sims J, Taguaim M, Hanson C, Cui X. United States Patent Application. 2016 Mar 3. 20160060316A1 |